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Abstract
Background: This is a community comparison study that examines persons living in a subdivision
exposed to petroleum products and mercury.
Methods: We compared their health status and questionnaire responses to those living in another
community with no known exposures of this type.
Results: Pristane house dust among the exposed homes was higher than in the comparison
communities. The exposed subdivision has higher ambient air mercury levels compared to the
control community. The prevalence of rheumatic diseases (OR = 10.78; CI = 4.14, 28.12) and lupus
(OR = 19.33; CI = 1.96, 190.72) was greater in the exposed population compared to the
unexposed. A higher prevalence of neurological symptoms, respiratory symptoms and several
cardiovascular problems including stroke (OR = 15.41; CI = 0.78, 304.68) and angina (OR = 5.72;
CI = 1.68, 19.43) was seen.
Conclusion: There were statistically significant differences in B cells, Natural Killer Cells, gamma
glutamyl transferase, globulin and serum calcium levels between control and exposed subjects.
Background
Systemic lupus erythematosus (SLE or lupus) is an
autoimmune disease in which the body produces anti-
nuclear antibodies that attack healthy tissues leading to
inflammation and damage to various body tissues. Lupus
can affect many parts of the body, including the joints,
skin, kidneys, heart, lungs, blood vessels, and brain. It is a
chronic, complex, and potentially fatal multi-system
inflammatory disorder that can be difficult to diagnose
[1,2]. No single laboratory test confirms a diagnosis of
SLE. Many physicians use the American College of Rheu-
matology's "Eleven Criteria of Lupus" to aid in the diag-
nosis where the appearance of four of the "Eleven Criteria
of Lupus" qualifies as a positive diagnosis of Lupus [2]
(Figure 1).
SLE can occur at any age and in either sex. However,
women are more likely to have SLE and women of color
are more likely to have SLE compared to white women
[3]. Migration studies suggest that environmental factors
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play a role in the development of SLE [4]. Residents living
near industrial emissions or environmental contamina-
tion have been shown to have an increase prevalence of
SLE [5,6]. Research indicates that a combination of
genetic and environmental factors can trigger the develop-
ment of SLE, however there is a need for additional
research to identify and characterize the specific exposures
that contribute to the incidence and aggravation of SLE
[7,8].
Animal studies suggest that pristane and mercury may be
environmental triggers for SLE [9-15]. It has been demon-
strated that both pristane and mercury will induce a con-
dition in mice that mimics clinical features and the
autoantibody pattern characteristic of SLE in humans. We
know of no reports in the medical literature of SLE in
humans following exposure to pristane. There have been
case reports linking mercury to autoimmune disease in
humans and a recent epidemiologic study of occupational
risk factors for SLE identified mercury as a potential causal
agent (OR = 3.6; 95% CI = 1.3,10.0) [7-10].
We investigated an apparent cluster of SLE cases in a com-
munity in Hobbs, New Mexico. This investigation was ini-
tiated by residents of a six square block area who noted an
excess of SLE cases in their neighborhood. Most of the
cases occurred in a new subdivision built on land that was
an active oilfield from 1927 until the late 1960s. This sub-
division was built on that site in 1976. Some of the homes
were built on ground that had previously been used as a
pit for oil field waste, which was estimated to be 200 feet
long and 30 feet wide.
The residents experienced petroleum and/or rotten egg
odors inside their homes on frequent occasions. They also
found black oily material oozing out of the ground either
spontaneously or when digging in the soil around their
property. The residents sought legal advice because they
were concerned that there was a connection between the
apparent residual oil field waste and the elevated SLE clus-
ter in their neighborhood.
There was a tank battery and several active oil wells
located directly to the west of the subdivision which con-
tinued operating until 2000 (Figures 2 &3). The oil com-
pany had installed a vapor recovery system for these oil
wells and an acompanying tank battery to reduce vapors
escaping from the storage tanks in 1969. When a lawsuit
was filed the oil company investigated the area and based
on the results of their investigation, closed down the tank
battery and purchased the three homes closest to that tank
battery site. The surface soil from the tank battery and
home sites was transferred to a hazardous waste site
because of very high Total Petroleum Hydrocarbons
(TPH). Soil testing for metals, semi-volatiles and polycy-
clic aromatic hydrocarbons (PAHs) at other nearby homes
did not reveal levels high enough to oblige remediation.
Both soil and air testing by the oil company and the
experts retained by the plaintiffs' counsel revealed the
presence of aromatic hydrocarbons including benzene,
toluene, ethylbenzene, xylene, pristane and phytane. Peo-
ple are still living in the remaining adjacent homes. We
compared the health status of 90 residents along with
their environmental and biomonitoring test results to a
reference population.
Methods
Study design
This is a community comparison study that examines per-
sons living in a subdivision exposed to petroleum prod-
American College of Rheumatology – The "Eleven Criteria" for diagnosis of SLE Figure 1
American College of Rheumatology – The "Eleven Criteria" for diagnosis of SLE.
1.  Malar rash: butterfly-shaped rash across cheeks and nose  
2.  Discoid (skin) rash: raised red patches  
3.  Photosensitivity: skin rash as a result of unusual reaction to sunlight  
4.  Mouth or nose ulcers: usually painless  
5.  Non-erosive Arthritis (bones around joints do not get destroyed): in 2 or more joints with tenderness, swelling, or 
effusion  
6.  Cardio-pulmonary involvement: inflammation of the lining around the heart (pericarditis) and/or lungs (pleuritis)  
7.  Neurologic disorder: seizures and/or psychosis/cognitive dysfunction  
8.  Renal (kidney) disorder: excessive protein in the urine, or cellular casts in the urine 
9.  Hematologic (blood) disorder: hemolytic anemia, low white blood cell count, or low platelet count  
10. Immunologic disorder: antibodies to double stranded DNA, antibodies to Sm (smooth Muscle), or antibodies to 
cardiolipin  
11. Antinuclear antibodies (ANA): positive test in absence of drugs known to induce it Environmental Health 2007, 6:8 http://www.ehjournal.net/content/6/1/8
Page 3 of 15
(page number not for citation purposes)
ucts and mercury and compares their health status and
questionnaire responses to those living in another com-
munity with no known exposures of this type. A volunteer
sample of 90 adults from the exposed neighborhood com-
pleted a questionnaire and donated blood for the meas-
urement of pristane, pristanic acid and phytane. We
compared the environmental exposures and question-
naire responses and pristane/phytane blood levels to
those living in another community with no unusual expo-
sures to these contaminants. We compared the observed
prevalence of SLE in this community with values reported
in the literature. Exposed study participants were all plain-
tiffs in a lawsuit.
Setting and study populations
Exposed Population – Hobbs, New Mexico is a predomi-
nantly Caucasian (63.5%) town of 28,657 residents
located in Lea County on the southeast corner of New
Mexico, 5 miles from the Texas border [16]. Hobbs was
founded in 1907 as an agricultural and ranching commu-
nity and became prominent after the discovery of oil in
1928. Hobbs is known as the oil capital of New Mexico
[17]. Numerous oil and gas wells are scattered throughout
the area and this industry is the principal source of
employment in Hobbs. We estimated a total population
of 1490 residents in the study neighborhood by counting
532 homes and estimating 2.8 individuals in each house-
hold. The bulk of the SLE cases are on two streets that
roughly correspond to the location of the oil field waste
pit until it was covered with fill dirt in the late 1960's. The
study population of 90 adults had lived in the area for at
least two years, and voluntarily enrolled in the study. We
assumed that the rest of community did not have SLE.
Comparison Population – One hundred and twenty nine
volunteers from a similar southwestern town without
unusual chemical exposures were recruited through a
church. We invited the members to participate in the
study by filling out a questionnaire and volunteering to
have blood drawn for biomonitoring. As with the exposed
population, trained and experienced proctors adminis-
tered a nearly identical questionnaire to all volunteers in
small groups. The questionnaire differed only with respect
to questions regarding exposure experiences unique to the
Photograph of Oil Field in Relation to Residents Homes Figure 2
Photograph of Oil Field in Relation to Residents Homes.Environmental Health 2007, 6:8 http://www.ehjournal.net/content/6/1/8
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Hobbs neighborhood. The control subjects were paid a
small fee for their participation. The control town was
matched for size, altitude, and demographics. The control
population was not free of unusual petroleum hydrocar-
bon exposure. Fifteen of the controls had been raised in
Bakersfield a town similar to Hobbs with many nearby oil
fields. Furthermore, the town is the site of a large railroad-
switching yard. Given that Hobbs has a large Hispanic
population we note some possible dietary issues specific
to Hispanic populations (herbal teas, etc.).
Data collection
The questionnaire obtains data on demographics includ-
ing age, gender, occupational and residential history as
well as medical, social and behavioral history. Other top-
ics covered in the questionnaire are health symptoms, dis-
eases, surgeries, medications, family history, income,
chemical exposures, and life style measures including
smoking and alcohol drinking. One unlikely symptom
question is designed to test for the veracity of the
responses provided. Questionnaire responses are
machine-readable, scanned on-site and verified before
subjects leave. This basic questionnaire has been used in
prior studies of exposed and unexposed groups [18].
Case definition
We defined a case of SLE as an individual who had
received a physician's diagnosis. We confirmed the diag-
nosis with medical records to confirm that the diagnosis
had been reached in accordance with American Rheuma-
tology Association's "Eleven Criteria of Lupus" [12]. We
excluded cases that were diagnosed within 6 months of
moving to the neighborhood or cases that were diagnosed
more than 5 years after moving away. This criteria for
diagnosis is consistent with previously published studies
[5,19].
Exposure assessment
House dust
We collected house dust samples from residents who per-
mitted access to their homes. House dust samples were
collected in the exposed and control community from 2/
27/03 to 3/1/03 by Stone Lions Environmental Corpora-
tion (Rolling Hills Estates, CA). A total of 19 house dust
Close up Photograph of Tank Battery in Relation to one of the two exposed Streets Figure 3
Close up Photograph of Tank Battery in Relation to one of the two exposed Streets.Environmental Health 2007, 6:8 http://www.ehjournal.net/content/6/1/8
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samples were collected in the exposed subdivision and
three additional samples were taken about 2 miles north-
east of the subdivision. Nine house dust samples were col-
lected from the control community.
Stone Lions Environmental Corporation collected house
dust samples using current state-of-the-art method for
household dust sampling which involves using the HVS-3
forensic vacuum or a Sears Kenmore canister vacuum
model 22085 sampling system. Dust was drawn into a
new vacuum bag, which was removed after each house.
The vacuum bags were immediately placed into a double
Ziploc bag and labeled accordingly. Samples were col-
lected in various places in each house depending on the
availability of dust. The primary locations were attic,
heater vents, windowsills, tops of furniture and appli-
ances, tops of doorways and doorway frames, exposed
shelves, and carpet (only for houses with minimal dust
elsewhere). All cleaning and bag removal activities were
performed while wearing powder free surgical gloves. The
samples were analyzed for analytes, polycyclic aromatic
hydrocarbons (PAHs), total petroleum hydrocarbons
(TPH), radiochemistry, pristane and phytane. Metals,
PAHs, and TPH were analyzed by West Coast Analytical
Services (Santa Fe Springs, CA). Metals were analyzed
using Inductively Coupled Plasma – Mass Spectrometry.
PAHs were analyzed using EPA method 625/8270C/SIM.
TPH were analyzed using EPA method 418.1. Radiochem-
istry was analyzed at Fruit Growers Laboratory (Santa
Paula, CA) using 901.0 (Gamma isotopic and 9310 (Radi-
ochemistry). Pristane and phytane exposures were ana-
lyzed at Humble Geochemical Services (Humble, Texas)
using high-resolution gas chromatography. This method
to measure and quantify pristane and phytane in crude oil
is standard in the petroleum industry. The petroleum
industry uses pytane/pristane fingerprints to determine
the source of crude oil.
Air monitoring
An ambient air monitoring station for volatiles and
reduced sulfur compounds was established at a site
located directly on the old waste pit in the exposed subdi-
vision. The site was located on a front lawn within a 10 by
10 foot chain link fence. Silica-lined Summa canisters
were used to collect 24 ambient air samples on a schedule
of approximately once every six days. The first sample was
collected on October 18th, 2002 and the final sample was
collected on February 11th, 2003. Over that period of five
months, nineteen 24-hour samples were collected includ-
ing one field blank. Canister preparation and sample
analyses were performed by Zymax Envirotechnology
(San Luis Obispo, California). Each sample was analyzed
for volatile organic compounds (VOCs) and reduced sul-
fur compounds. VOCs were analyzed using EPA method
TO-14 GC/FPD.
A meteorological station (Davis Instruments) was
installed at the same location as the ambient air-monitor-
ing site. Instruments measuring wind speed, wind direc-
tion, ambient temperature, pressure, relative humidity
and rainfall were mounted on a two-meter tower. Those
parameters were recorded at half-hour intervals for the
duration of the ambient air-monitoring period.
Mercury ambient air testing
The Lumex Zeeman Mercury Analyzer RA-915+ was used
to measure the ambient air concentration of mercury from
various locations inside and outside the homes in both
the exposed and control communities. 30-second ambi-
ent air samples were taken in the center of each room and
on the front porch.
Biomonitoring
General health screening panel
A trained phlebotomist collected blood and urine from
volunteers from both the exposed and control communi-
ties. One tiger top, two lavender tops and one grey top (for
urine) was shipped overnight on ice to Pacific Toxicology
Laboratories (Woodland Hills, California) for analyses. A
complete blood count, chemistry panel and a urinalysis
were performed using standard laboratory techniques.
Lymphocyte subpopulation analysis
The Lymphocyte Subpopulation Analysis (Enumeration
Panel) was done to estimate the distribution of the com-
mon lymphocytes. A trained phlebotomist collected one
yellow top of blood from both exposed and control par-
ticipants and shipped overnight on ice to Immunoscience
Laboratories (Beverly Hills, California)
Pristane and phytane
Pristane is a straight chain seventeen carbon alkane; phy-
tane is an eighteen-carbon alkane. Pristanic acid is a
metabolite of pristane. All three were measured in blood
of exposed and comparison subjects by Southwest
Research Institute (San Antonio, Texas). An aliquot of 1
ml of serum was removed and 20 µl of phosphoric acid
was added to the serum sample. Pristanic acid-d3 was
then added to the serum to monitor the extraction effi-
ciency of pristanic acid. The serum was extracted twice
using 5 ml hexane saturated with acetonitrile. The organic
layer was decanted and was concentrated to 1 ml. The
organic extract was then derivatized using diazomethane
to convert pristanic acid to its ester form. After derivatiza-
tion, the organic extract was further concentrated to 0.2
ml and serum samples were ready for GC/MS analysis.
The GC/MD instrument was calibrated using a 5-pt cali-
bration curve. The range was from 0.8 – 0.25 ug/ml. The
instrument was operated under selected ion monitoring
(SIM) mode to enhance sensitivity.Environmental Health 2007, 6:8 http://www.ehjournal.net/content/6/1/8
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Data analysis
Unadjusted frequencies and percents for age, gender, eth-
nicity, smoking status and education are presented for
exposed and unexposed populations. P-values for the
unadjusted differences in percents between the two
groups were estimated using the Pearson chi square test.
Odds ratios and 95% confidence intervals are estimated
for binary health outcomes using logistic regression to
compare exposed and unexposed populations while con-
trolling for age, gender, education and race/ethnicity. The
Hosmer and Lemeshow goodness-of-fit test (Hosmer and
Lemeshow 1989) for the case of a binary response model
was performed for each model. In this procedure, the sub-
jects are divided into approximately ten groups of roughly
the same size based on the percentiles of the estimated
probabilities. The discrepancies between the observed and
expected number of observations in these groups are sum-
marized by the Pearson chi-square statistic, which is then
compared to a chi-square distribution with t degrees of
freedom, where t is the number of groups minus n. By
default, n  = 2. A small p-value suggests that the fitted
model is not an adequate model.
Odds ratio and confidence intervals are estimated for
those health outcomes where the response possibilities
include a scale from 1 to 11 using multinomial logistic
regression models. The odds ratio is interpreted as the
odds of the exposed reporting a higher response from the
1 – 11 scale compared to the unexposed. All the ordinal
outcome variables were fit into the ordinal logistic model
and the goodness of fit was tested using the chi-square sta-
tistic.
All statistical analyses were performed using SAS 8.0.
Results and discussion
Ninety adult volunteers from the exposed community and
129 adults from the comparison community participated
in the study (Table 1). The age, gender and smoking his-
tory (ever/never) were similar between the two groups.
The exposed population was more diverse in terms of
race/ethnicity; the comparison group was Caucasian.
Level of education was higher in the comparison group.
Environmental measures
House dust samples for pristane and phytane were higher
in the exposed homes (Table 2). Pristane and phytane
were found in every sample tested from both the exposed
and unexposed communities, however, significantly
higher values were found in the exposed community. Pris-
Table 1: Demographic frequencies in Hobbs* and in a control community**
Exposed Unexposed
No. % No. % P-value
Age Category
18–34 35 37.63 37 28.68 0.85
35–49 35 37.63 62 48.06
50–64 19 20.43 28 21.71
65+ 4 4.30 2 1.55
Total 93 129
Race/Ethnicity
Hispanic 44 48.89 5 3.88 <0.0001
White 29 32.22 121 93.80
African American 12 13.33 0 0
O t h e r s 55 . 5 532 . 3 3
Gender
Male 34 37.36 61 47.29 0.21
Female 57 62.64 68 52.71
Ever Smoked
Yes 35 38.89 52 40.31 0.83
No 55 61.11 77 59.69
Education Level
Less than 9th grade 6 6.45 0 0 <0.0001
9 – 11th grade 22 23.66 13 10.08
12th/Vocational/
Some College
57 61.29 86 66.67
College Graduate 8 8.60 30 23.26
*a residential population exposed to petroleum products and other environmental contaminants
**no known exposures.Environmental Health 2007, 6:8 http://www.ehjournal.net/content/6/1/8
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tane house dust among the exposed homes was higher
than in the comparison communities. House dust sam-
ples for mercury were not elevated in exposed homes
(data not shown).
Air sampling by the oil company for pristane and phytane
in the exposed neighborhood during both at baseline and
soil removal operations consistently showed positive val-
ues (Table 3). The baseline air sampling was conducted in
July of 2001. The air samples were taken during the reme-
diation that lasted approximately 6 months starting in
March of 2002. The SVOC samples were obtained in the
exposed subdivision at 6 sites.
Results of ambient mercury air measurements are dis-
played in Table 4. Outdoor air blanks (front porch read-
ings) were consistently much lower than indoor values.
Data is not shown. Summary of the ambient mercury air
measurements are displayed in Table 5. The exposed sub-
division has nearly 6.2 times higher mercury levels com-
pared to other locations in Hobbs located two miles away
and nearly 2.5 times higher mercury levels compared to
the control community.
Biomonitoring
One of twenty-five (4.0%) from the comparison subjects
and five of twenty (25%) from the exposed who were
tested had detectable positive blood levels for pristane,
phytane and/or pristanic acid. Each subject who had a
detectable level of pristane, phytane and/or pristanic acid
also had either a frank diagnosis of lupus or common
symptoms associated with immune system disorders. The
students' t-test produces a p-value of < 0.05 for this differ-
ence.
Blood samples were obtained from 97% (87/90) of the
exposed subjects. Forty-three of 90 (47%) exposed sub-
jects and 37/129 (28%) unexposed subjects agreed to pro-
vide additional vials of blood for natural killer cell and
CD 19 (B cell) analysis. Ten additional control subjects
participated only in the natural killer cell and CD 19 (B
cell) analysis (Table 6). There were biologically and statis-
tically significant differences in B cells, Natural Killer
Cells, gamma glutamyl transferase, globulin and serum
calcium levels. Creatinine Phosphokinase (CPK) was not
significantly different for the overall group; however, an
examination of blood results for men only reveals the
mean value in the exposed population is 220 versus 139
in the comparison group. Five of the nineteen exposed
males (26.3%) had CPK above the laboratory normal of
269 IU/L and none of the comparison men were above
that value. There was no influence by alcohol or other fac-
tors.
Disease prevalence and symptoms
Hosmer and Lemeshow tests were performed on all of the
outcomes modeled with logistic regression. All of the p-
values are between 0.22 and 0.99. These results indicate
that the data fit the model adequately in each case. For
data scaled data modeled with multinomial logistic
regression, the chi-square test for goodness of fit indicated
an appropriate fit for each of the modeled outcomes.
Lupus cases were confirmed by both phone call follow up
and review of medical records (Table 7). The prevalence of
rheumatic diseases and lupus was greater in the exposed
population compared to the unexposed (OR = 10.78; CI =
4.14, 28.12 and 19.33; 1.96, 190.72, respectively) (Table
8). The wide confidence interval for lupus reflects the sin-
gle case found in the unexposed community. Increased
prevalences of symptoms thought to be predictive of
autoimmune disorder were found in the exposed commu-
nity including: numb fingers, mouth sores, and persistent
rash on the cheeks and pain on deep breath.
The presence of neurological symptoms was elevated in
the exposed community including: dizziness, lighthead-
edness, loss of balance, extreme fatigue, sleep disorders,
lack of concentration and memory loss (Table 9).
A higher prevalence of several cardiovascular problems
occurred in the exposed population including stroke and
Table 2: Results for pristane and phytane house-dust sampling for Hobbs, Hobbs-Control, and Control Community.
Sample Group/Chemical Pristane* Phytane*
Avg SD Max Min Avg SD Max Min
Hobbs (n = 19) 480.831 784.216 2441.230 13.770 262.522 542.694 2464.530 18.750
Hobbs-Control** (n = 3) 42.437 25.868 66.290 14.940 155.277 153.763 324.320 23.730
Tehachapi (n = 9) 99.029 116.491 349.310 17.940 223.969 138.587 557.440 85.220
* results in ppm
** Samples collected 2 miles outside of the Westgate Subdivision
AVG – Average
SD – Standard Deviation
Max – Maximum
Min – MinimumEnvironmental Health 2007, 6:8 http://www.ehjournal.net/content/6/1/8
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angina (OR = 15.41; CI = 0.78, 304.68 and 5.72; 1.68,
19.43, respectively) chest tightness and pain in the chest
(Table 10). Again, the wide confidence interval for stroke
reflects the paucity of stroke sufferers in the comparison
community. No difference was found for the overall
measure of heart disease or myocardial infarction.
Respiratory symptoms were significantly elevated in the
exposed population including shortness of breath and
wheezing, cough with blood or mucus, dry cough and
chronic bronchitis (Table 11).
Other elevated symptoms include gastrointestinal prob-
lems like diarrhea, constipation, nausea, stomach swell-
ing and loss of appetite (Table 12). Diabetes was also
more prevalent in the exposed population; the difference
nearly reached the level of statistical significance at the
0.05 level (OR = 3.26, CI = 0.96, 11.10; p-value = 0.06).
Discussion
We not only observed a significantly increased prevalence
of SLE but also an increase of cardiovascular, neurological
and respiratory problems in this subdivision of Hobbs,
New Mexico. The literature reports a prevalence for SLE
that varies from 14.6 to 50.8 cases/100,000. The highest
rates are seen in African Americans [4,20-22]. If all the
cases reported here in this one neighborhood were the
only cases in the entire town of Hobbs, we would have a
Table 4: Results for ambient air mercury sampling for Hobbs, Hobbs-Control, and Control Community.
Sampling Group Address MULTIPLE SAMPLES AT EACH RESIDENCE* Average
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Hobbs Point 1 19 18 21 19 21 19.6
P o i n t  21 71 81 8 1 8 2 0 1 9 1 91 8 1 8 . 3 8
Point 3 7 8 8 10 17 17 15 16 16 12.67
Point 4 46 73 79 82 68 94 97 157 171 67 103 96 72.3 90 19 87.64
P o i n t  51 11 53 2 1 7 3 4 2 3 2 42 82 72 82 0 2 3 . 5 5
P o i n t  6 1 1 9 1 0 9 1 21 21 1 1 4 1 0 1 0 . 8 9
P o i n t  71 31 41 3 1 3 1 5 1 3 1 4 1 3 . 5 7
P o i n t  83 22 43 3 2 7 3 0 3 5 3 03 23 5 3 0 . 8 9
P o i n t  91 91 51 4 1 291 5 1 42 1 2 . 5
Point 10 14 13 13 14 10 12 11 12.43
Hobbs Control** Point 11 7 5 7 6 9 9 7 7.14
Point 12 4 0 0 0 0 0 0.67
Control Point 13 15 17.5 15 19 19 21 17.75
Point 14 2 5 6 6 7 5.2
Point 15 16 15 16 8 13 28 31 30 29 29 32 22.45
P o i n t  1 6 799 1 2 9.25
P o i n t  1 7 677 8 7
Point 18 18 18 18 12 16.5
Point 19 9 7 6 1 7 5 5.83
P o i n t  2 04 5 63249 4 . 7 1
Point 21 10 11 8 16 12 6 10.5
Point 22 5 6 5.5
* 30-second averages, results in nanograms per cubic meter
**Samples collected 2 miles outside of the Westgate Subdivision
Table 3: Air monitoring data for pristane, phytane and PAHs taken at baseline and during trenching operations*
Summary Statistics for SVOC Air Monitoring – 
Baseline
Summary Statistics for SVOC Analysis of Air – 
Trenching Operations
Compound Concentration (ng/m3) Concentration (ng/m3)
Minimum Maximum Mean Minimum Maximum Mean
Phytane 6.10 145 37.7 7.85 83.9 43.1
Pristane 4.43 182 50.5 8.21 110 41.9
Total PAH 57.0 655 178 89.4 769 224
*Sampling conducted by Oil CompanyEnvironmental Health 2007, 6:8 http://www.ehjournal.net/content/6/1/8
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SLE prevalence of 45 cases/100,000 (13 cases/28,657).
However, that method of calculation would most likely
be inaccurate because there are no doubt other SLE cases
in Hobbs. Thirteen SLE cases are found on two blocks
alone. This two-block area was on or near the site of the
oil field waste pit and presumably would reflect a higher
exposure than other areas. Taking only the exposed neigh-
borhood we obtain a lupus prevalence of 872/100,000
(13 cases/1490 [532 homes × 2.8 individuals in each
household]). In addition to the diagnosed SLE, there is an
increased prevalence of reported immunologic symptoms
and or problems in the exposed population compared to
controls. Rheumatic disease is 10 times more likely; SLE is
10 times more likely in the exposed compared to their
unexposed counterparts. Other symptoms common
among those with immune problems are also reported
with increased frequency in the exposed population
including mouth sores, numbness, and rash.
The magnitude of the prevalence of SLE may be under-
stated for three reasons. First there were other possible SLE
cases however we could not confirm a physician diagnosis
in their medical records. Second we compared the preva-
lence using the highest-available expected estimates for
prevalence to be conservative. Third, we did not collect
data on the entire subdivision or town; therefore we may
not have identified all the cases of SLE, even in the
exposed subdivision.
In addition to the finding of a significant increase in the
prevalence of SLE in the exposed neighborhood the lym-
phocyte testing of the exposed population's immune sys-
tem shows significant abnormality compared with the
controls. The lymphocyte population of the exposed resi-
dents is not normal. Natural Killer Cells (NKC) are signif-
icantly lower in the exposed population. Analysis of B-
lymphocytes shows that the exposed population has sig-
nificantly higher B-lymphocytes compared to controls.
This finding is consistent with the known compensatory
effects of B cells when other lymphocytes are inhibited.
The natural killer cells are reduced causing compensatory
changes in B-cells. Such a decrease of an essential compo-
nent of the body's immune cells indicates a potentially
significant impairment with implications for increased
susceptibility to infection and cancer. The data presented
here reports for the first time an adverse effect on lym-
phocytes numbers associated with environmental expo-
sures to oil field waste. The spectrum of long-term health
effects arising from this exposure will require long-term
follow-up. At the very least this data demonstrates a per-
turbation of the immune system, which in concert with
the finding of a significant cluster of SLE indicates that the
exposure in this neighborhood is likely have additional
effects on the residents, even those who have not been
diagnosed with SLE. We are attempting to further charac-
terize the immunological defect that is present in these
residents.
Calcium is tightly regulated in the body because it is an
essential mineral in many body functions. Even slight
changes in serum calcium reflect alterations in hormone
balance. In this case, there is a significantly higher serum
calcium level in the exposed population. This finding
reflects differences in hormone balance and is consistent
Table 6: Ordinary least squares regression analysis comparing blood results between exposed and unexposed, controlling for age.
Adults Exposed Unexposed Comparison Estimates
Number Mean (SD) Number Mean (SD) Parameter Estimate P-value
% CD 19 (B-cell) 43 18.07(6.11) 47 14.02(4.68) 3.98 0.0006
% Natural Killer Cells1 43 10.77(5.65) 47 14.26(7.33) -3.41 0.01
Total bilirubin 87 0.61(0.23) 37 0.54(0.16) 0.07 0.12
gamma-Glutamyl transferase (IU/L) 87 40.07(50.25) 37 19.30(11.53) 21.60 0.01
Globulin (mg%) 87 3.02(0.50) 37 2.86(0.34) 0.15 0.09
Serum CALCIUM (mg%) 87 9.71(0.38) 37 9.23(0.36) 0.48 <0.0001
Creatinine Phosphokinase (IU/L) 87 127.44(90.63) 37 110.43(54.02) 16.02 0.32
1. Natural Killer Cells = CD16 + 56+/CD45+
SD = Standard Deviation
Table 5: Summary Results for ambient air mercury sampling for 
Hobbs, Hobbs-Control, and Control Community.
Sample Group/Chemical Mercury*
Avg SD Max Min
Hobbs 24.21 31.34 171.00 2.00
Hobbs-Control** 3.90 3.67 9.00 0.00
Tehachapi 10.47 8.08 32.00 1.00
* 30-second averages, results in nanograms per cubic meter
**Samples collected 2 miles outside of the Westgate Subdivision
AVG – Average
SD – Standard DeviationEnvironmental Health 2007, 6:8 http://www.ehjournal.net/content/6/1/8
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with the endocrine disrupting effects of environmental
pollutants. In this case the chemical agent or agents that
may explain this phenomenon are unknown.
Creatinine Phosphokinase (CPK) is an enzyme, which
appears in the blood. Elevations of this enzyme indicates
damage to either heart, brain or muscle tissue The cause of
the elevated CPK in the exposed males is another objective
indication of adverse effects in the residents most logically
as a result of their environmental exposure to oil field
waste. As with the disruption of calcium metabolism the
chemical agents responsible are unknown. In our experi-
ence CPK is often elevated in patients with exposure to
neurotoxic agents. It is likely that the source of the ele-
vated serum CPK in this case is from damage to the nerv-
ous tissue.
The residents in the exposed community were exposed to
higher than usual background levels of various hydrocar-
bons including benzene, xylene, toluene, pristane, phy-
tane and polycyclic aromatic hydrocarbons (PAHs). We
found higher levels of air mercury and house dust pris-
tane/phytane in the affected neighborhood compared to
other areas of Hobbs and the control town. Mercury is
very volatile and so the major route of exposure would be
through vapor inhalation. Pristane/phytane on the other
hand is not volatile and it would be expected to be higher
in the house dust.
Mercury is one of the few chemicals that are conclusively
known to cause adverse immune system disruption in ani-
mals and humans. Exposure to mercury can depress or
stimulate the immune system [23]. Inorganic mercury salt
poisoning which was once a common cause of renal fail-
ure is now less common [24]. Recent research has been
done on the adverse effects of mercury on various compo-
nents of the immune system [25-31]. Some strains of
rodents develop autoimmunity upon very low exposure
to mercury while other strains are not affected
[9,23,32,33]. This finding reveals a key element to under-
standing mercury toxicity and the immune system. Only
those persons with the susceptibility will develop the dis-
ease. The occurrence of autoimmunity in animal studies
depends on the dose, chemical form or strain of animal.
Animal studies show that low doses of mercury damages
T cells, leads to immune system dysfunction and induces
autoimmunity [9,34-47]. The immune reaction in
humans to mercury exposure is varied. Humans have
Table 8: Estimated odds ratios and confidence intervals for autoimmune disorders comparing residents to controls
Exposed N(%) or mean ± s.d. Unexposed N(%) or mean ± s.d. Odds Ratio 95% Confidence Interval P-value
Rheumatic Diseases 33 (39.29) 16 (12.40) 10.78 4.14, 28.12 <0.0001
Systemic lupus erythematosus 13(14.29) 1 (0.78) 19.33 1.96,190.72 0.01
Immune 9 (11.11) 1 (0.78) 26.44 2.67,261.50 0.005
Anemia 22 (26.19) 29 (22.48) 1.14 0.49, 2.65 0.76
Numbness in Fingers 49 (58.33) 34 (26.36) 3.96 1.93, 8.15 <0.0002
Mouth Sores 18 (21.43) 6 (4.65) 5.66 1.78, 18.03 0.03
Rash on the Cheeks 17 (20.24) 4 (3.10) 8.27 2.20, 31.13 0.002
Rash from Sunlight 17 (20.24) 11 (8.53) 1.44 0.50, 4.13 0.50
Pain on Deep Breath 19 (22.62) 7 (5.43) 11.04 3.68, 33.13 <0.0001
*Odds ratio and confidence intervals are estimated using logistic regression
Controlled for age, gender, race/ethnicity, education and smoking history
Table 7: Exposure information for Lupus cases in Westgate Subdivision
Patient From Age To Age Total years Gender Date of Birth (age)
1 43 Present 14 Female 8/21/45 (57)
2 26 Present 22 Female 11/6/54 (48)
3 11 22 11 Female 1/4/76 (27)
4 30 Present 19 Female 1/23/54 (49)
5 37 Present 12 Female 7/3053 (49)
6 31 45 14 Male 6/7/56 (46)
7 33 35 2 Female 8/7/45 (57)
8 38 43 5 Female 12/4/39 (63)
9 28 30 2 Female 1/21/63 (40)
10 62 72 10 Female 12/20/26 (76)
11 18 40 22 Female 4/20/59 (43)
12 35 49 14 Female 9/23/51 (51)
13 3 29 26 Female 12/12/1972 (29)Environmental Health 2007, 6:8 http://www.ehjournal.net/content/6/1/8
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increased activity of the immune system leading to
autoimmunity [48] or sensitivities to the environment
[49,50]. On the other hand there can be immune suppres-
sion with decreases in immune defenses such as macro-
phage function [51]. Low-level chronic exposure to
mercury has been associated with Crohn's disease,
endometriosis, lupus, and other autoimmune processes
[8,28,52]. There have been case reports linking mercury to
autoimmune disease in humans and a recent epidemio-
logic study of occupational risk factors for SLE identified
mercury as a potential causal agent (OR = 3.6; 95% CI =
1.3,10) [7-9].
Cooper's epidemiologic study of human exposure to mer-
cury reveals increased rates of immunologic disease. Asso-
ciations were seen with self-reported occupational
exposure to mercury (OR = 3.6; 95% CI = 1.3, 10.0) and
reported a significantly increased prevalence of SLE
among dental workers (OR = 7.1; 95% CI = 2.2, 23.4) [7].
None of our subjects had been dental workers. Mercury's
presence can be explained in this community by mercury
presence in crude oil and its use in instruments found in
oil fields [53-55]. Studies have implicated residents living
near industrial emissions or environmental contamina-
tion to increased prevalence of SLE [5,6].
In 1976, Cancro and Potter injected mineral oil or the
pure alkane pristane into mice [56]. Cancro and Potter
reported that in as little as three days plasmacytosis was
evident [56]. Pristane injected into a rat also induces
arthritis [57-61]. In certain strains of mice. pristane expo-
sure is known to induce autoimmunity and systemic
lupus erythematosus [12,13,62-73]. Satoh in 2000
reported that pristane was able to induce lupus in virtually
any strain of mouse regardless of its genetic background
[13]. Phytane is also likely to have a similar effect because
Table 10: Odds ratios and confidence intervals for cardiovascular disorders between exposed and unexposed residents.
Exposed N(%) or mean ± s.d. Unexposed N(%) or mean ± s.d. Odds Ratio 95% Confidence Interval P-value
Heart Disease* 5 (6.17) 4 (3.10) 1.80 0.33, 9.66 0.50
Acute Myocardial Infarction * 3 (3.57) 3 (2.33) 2.11 0.17, 25.93 0.56
Stroke* 5 (5.95) 1 (0.78) 15.41 0.78, 304.68 0.07
Angina* 15 (17.86) 5 (3.88) 5.72 1.68, 19.43 0.005
Rhythm 10 (12.35) 18 (13.95) 0.61 0.22, 1.68 0.34
Chest tightness** 3.74 ± 2.82 1.92 ± 1.54 5.97 3.13, 11.40 >0.0001
Palpitations** 3.03 ± 2.69 2.35 ± 1.98 1.64 0.87, 3.07 0.12
Pain in Chest** 3.42 ± 2.88 1.73 ± 1.65 4.24 2.21, 8.14 <0.0001
*Odds ratio and confidence intervals are estimated using logistic regression
** Odds ratio and confidence intervals are estimated using multinomial logistic regression models with generalized estimating equations (GEE); odds 
ratio interpreted as the odds of exposed being in a higher category compared to unexposed. Respondents were asked to "score each question on a 
scale of 1 – 11, one representing never and 11 representing always.
Controlled for age, gender, race/ethnicity, education and smoking history
Table 9: Odds ratios and confidence intervals for neurologic and behavioral disorders comparing exposed and unexposed residents
Exposed N(%) or 
mean ± s.d.
Unexposed N(%) or 
mean ± s.d.
Odds Ratio 95% Confidence Interval P-value
Dizziness* 4.40 ± 3.10 2.25 ± 1.96 4.42 2.37, 8.24 <0.0001
Lightheadedness* 4.85 ± 3.12 2.65 ± 1.81 5.02 2.69, 9.34 <0.0001
Loss of balance* 3.68 ± 3.07 2.24 ± 1.73 2.83 1.53, 5.22 0.0009
Extreme fatigue* 6.97 ± 3.69 3.12 ± 2.40 11.50 5.94, 22.28 <0.0001
Somnolence* 5.08 ± 3.76 2.11 ± 1.86 4.99 2.66, 9.36 <0.0001
Can't fall asleep* 4.79 ± 3.79 2.89 ± 2.50 1.94 1.06, 3.54 0.03
Wake up frequently* 5.12 ± 3.79 2.91 ± 2.55 3.98 2.16, 7.36 >0.0001
Sleep soundly for only a few hours* 4.83 ± 3.59 2.81 ± 2.51 4.00 2.16, 7.40 >0.0001
Lack of concentration* 5.70 ± 3.73 3.76 ± 2.66 2.67 1.47, 4.84 0.001
Recent memory loss* 5.22 ± 3.82 3.76 ± 2.66 2.87 1.58, 5.23 0.0006
Decreased libido* 4.36 ± 4.00 2.92 ± 2.35 3.00 1.60, 5.59 0.0006
When driving in familiar areas, do you ever 
get lost or go the wrong way *
2.67 ± 2.73 1.55 ± 1.33 3.05 1.54, 6.08 0.002
* Odds ratio and confidence intervals are estimated using multinomial logistic regression models with generalized estimating equations (GEE); odds 
ratio interpreted as the odds of exposed being in a higher category compared to unexposed. Respondents were asked to "score each question on 
a scale of 1 – 11, one representing never and 11 representing always.
Controlled for age, gender, race/ethnicity, education and smoking historyEnvironmental Health 2007, 6:8 http://www.ehjournal.net/content/6/1/8
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of its similar structure and toxicity [72]. Pristane is a likely
candidate to be an environmental trigger for SLE in sus-
ceptible sub-populations. The authors wrote in their
paper "Finally, it may be worth noting that pristane is
found in mineral oil, shark oil, and many foods, raising
the possibility that environmental exposure to pristane
could be involved in the pathogenesis of some cases of
human SLE" [12].
It has been demonstrated that both pristane and mercury
will alter immune system function [57,58,74,75]. We are
not aware of any human cases of pristane induced SLE,
this study should encourage further research on autoim-
mune diseases and environmental exposures.
The fact that all of the subjects with pristane or phytane in
their blood have significant autoimmune diseases or
symptoms of autoimmune disease is consistent with the
animal models implicating pristane as a causal factor in
the development of SLE. Interestingly, the one control
subject with pristane and phytane in her blood reported a
rash after being in the sun and also a diagnosis of pleurisy.
These two symptoms are often antecedent to developing
lupus.
Some researchers question whether reliable data can be
obtained from participants involved in litigation. While it
is claimed that litigants exaggerate their symptoms we
know of no evidence that this is true, particularly when
Table 12: Odds ratios and confidence intervals for other disorders between exposed and unexposed residents
Exposed N(%) or mean ± s.d. Unexposed N(%) or mean ± s.d. Odds Ratio Confidence Interval P-value
Diabetes* 10 (12.35) 6 (4.65) 3.26 0.96, 11.10 0.06
Reduced sense of smell** 3.80 ± 3.53 2.12 ± 2.23 3.77 1.96, 7.25 <0.0001
Nausea** 4.54 ± 3.20 2.23 ± 1.51 4.82 2.58, 8.99 <0.0001
Loss of appetite** 3.80 ± 2.70 2.13 ± 1.49 3.44 1.86, 6.37 <0.0001
Stomach swells or is bloated** 5.07 ± 3.78 2.13 ± 1.80 6.76 3.46, 13.19 <0.0001
Constipation** 4.16 ± 3.36 2.68 ± 2.14 2.90 1.58, 5.35 0.0006
Diarrhea** 3.78 ± 2.89 2.55 ± 1.75 2.75 1.49, 5.06 0.001
Poor bladder control** 3.40 ± 3.59 2.34 ± 2.13 2.50 1.30, 4.82 0.006
Hair Loss* 33 (39.76) 6 (4.65) 14.12 4.57, 43.65 <0.0001
Seizures* 4 (4.76) 5(3.88) 0.85 0.18, 4.02 0.84
*Odds ratio and confidence intervals are estimated using logistic regression
** Odds ratio and confidence intervals are estimated using multinomial logistic regression models with generalized estimating equations (GEE); odds 
ratio interpreted as the odds of exposed being in a higher category compared to unexposed. Respondents were asked to "score each question on a 
scale of 1 – 11, one representing never and 11 representing always.
Controlled for age, gender, race/ethnicity, education and smoking history
Table 11: Odds ratios and confidence intervals for respiratory disorders between exposed and unexposed residents
Exposed Unexposed 95%
N(%) or mean ± s.d. N(%) or mean ± s.d. Odds Ratio Confidence Interval P-value
Pneumonia* 11(13.58) 18(13.95) 1.19 0.45, 3.15 0.72
Pleurisy* 5 (6.33) 4 (3.10) 1.48 0.29, 7.61 0.64
Chronic bronchitis* 16 (19.75) 3 (2.33) 17.4 4.06, 74.35 0.0001
Dry cough** 4.64 ± 3.21 2.36 ± 1.74 5.06 2.67, 9.60 <0.0001
Cough with mucous** 4.73 ± 3.51 2.79 ± 1.75 2.6 1.43, 4.73 0.002
Cough with Blood** 2.30 ± 2.55 1.11 ± 0.45 11.8 4.33, 32.03 <0.0001
Asthma Diagnosed by MD* 11 (13.41) 17 (13.18) 2.13 0.78, 5.82 0.14
Rhinitis* 24 (29.63) 21 (16.28) 3.45 1.49, 8.01 0.004
Sinusitis range** 4.57 ± 3.71 2.50 ± 1.91 2.62 1.43, 4.79 0.002
Short of Breath at Rest* 23 (27.38) 4 (3.10) 11.3 3.11, 40.98 0.0002
Short of Breath on Walking* 40 (48.19) 6 (4.65) 34.3 10.52, 112.09 <0.0001
Short of Breath Climbing Stairs* 52 (62.65) 34 (26.36) 6.17 2.81, 13.56 <0.0001
Wheezing* 24 (28.57) 7 (5.43) 19.2 5.59, 65.98 <0.0001
*Odds ratio and confidence intervals are estimated using logistic regression
** Odds ratio and confidence intervals are estimated using multinomial logistic regression models with generalized estimating equations (GEE); odds 
ratio interpreted as the odds of exposed being in a higher category compared to unexposed. Respondents were asked to "score each question on a 
scale of 1 – 11, one representing never and 11 representing always.
Controlled for age, gender, race/ethnicity, education and smoking historyEnvironmental Health 2007, 6:8 http://www.ehjournal.net/content/6/1/8
Page 13 of 15
(page number not for citation purposes)
examining averaged group responses. A study by the
Agency for Toxic Substance and Disease Registry (ATSDR)
revealed no evidence of "litigation bias" among subjects
being followed for health effects from trichloroethylene in
their drinking water with no statistically significant differ-
ence in the validity of the survey responses from litigant
versus non-litigant populations [76]. These authors write,
"Litigants are no more likely than non-litigant(s) to pro-
vide inaccurate or exaggerated responses."
Observational bias is unlikely to influence these results
because the techniques used to collect the data do not
require interpretation. In addition, there is no indication
that there would have been differential bias in this regard.
The questionnaires were filled out in a neutral environ-
ment supervised by trained proctors. All subjects were
given the same instructions. Recall bias is also unlikely to
affect the results, particularly when it comes to lupus.
Most people who were ever diagnosed with this disease
would never forget it.
Conclusion
Despite some possible limitations, the findings in this
study are compelling. The hypothesis that environmental
toxins may induce lupus is consistent with the known
ability of certain medications to cause SLE [77-79]. There
exists a plausible biological basis for such an association
[80]. Examples include the association of prolonged sil-
ica-dust exposure with scleroderma [81], the occurrence
of Raynaud's phenomenon, sclerodermatous skin
changes, and acroosteolysis among vinyl chloride workers
[82,83].
This study adds to the evidence implicating pristane and
mercury in the development of lupus and generates ques-
tions as to the possible synergistic effects of organic sol-
vents including pristane and phytane, mercury and other
exposures. Further research is needed to determine the
mechanism of effect for each of the suspected causal expo-
sures and to assess possible synergy between exposures.
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